- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Valiant Laboratories has announced a rights issue, offering up to 1.08 crore fully paid-up equity shares. The shares are priced at ₹75 each, aiming to raise up to ₹81.47 crore. Eligible shareholders will receive one rights share for every four shares held. This capital raise allows existing investors to increase their stake at a set price. Rights Entitlements (REs) will be credited to demat accounts and can be traded on exchanges. Shareholders are encouraged to use the ASBA process for applications. Unsubscribed REs will lapse, so active participation or renunciation is key for investors.